Table 3.
Base-line clinical and behavioral characteristics of DR-TB patients on second anti-TB drugs in Amhara Regional State public hospitals, Ethiopia, September 2010 to December 2017, (N = 570)
| Variables | Frequency | Percent (%) |
|---|---|---|
| Functional status | ||
| Working | 199 | 35.35 |
| Ambulatory | 172 | 48.31 |
| Bedridden | 92 | 16.34 |
| Second line regimen | ||
| E-Z-Cm-Lfx-Eto-Csa | 105 | 18.42 |
| Z-Cm-Lfx-Eto-Cs | 65 | 11.40 |
| Z-Cm-Lfx-Pto-Cs | 400 | 70.18 |
| HIV co-infection | ||
| Negative | 416 | 72.98 |
| Positive | 154 | 27.02 |
| Baseline hemoglobin | ||
| Anemic | 212 | 37.19 |
| Not anemic | 358 | 62.81 |
| Baseline body mass index(kg/m2) | ||
| < 18.5 | 402 | 74.86 |
| 18.5–24.9 | 135 | 24.14 |
| Comorbid conditions | ||
| Yes | 84 | 14.74 |
| No | 486 | 85.26 |
| Type of TB | ||
| Pulmonary | 502 | 88.07 |
| Extra-pulmonary | 44 | 7.72 |
| Disseminated | 24 | 4.21 |
| History of smoking | ||
| Yes | 77 | 13.51 |
| No | 493 | 86.49 |
| History of alcohol drinking | ||
| Yes | 86 | 15.19 |
| No | 480 | 84.81 |
| Drug abuse | ||
| Yes | 27 | 4.76 |
| No | 540 | 95.24 |
aE Ethambutol, Lfx Levofloxacin, Cm Capreomycin, Eto Ethionamide, Pto Protionamide, Cs Cycloserine, Z Pyrazinamide